Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.3 - WS Atkins - Amendment

7 Jun 2017 12:31

FORM 8.3

AMENDMENT 2(a) & 3(a)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose WS ATKINS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 02 June 2017
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,144,720 1.14% 963,199 0.96%
(2) Cash-settled derivatives:
18,595 0.02% 981,655 0.98%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,163,315 1.16% 1,944,854 1.94%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
0.5p ordinary Purchase 17 20.8250 GBP
0.5p ordinary Purchase 124 20.7750 GBP
0.5p ordinary Purchase 290 20.7650 GBP
0.5p ordinary Purchase 343 20.8050 GBP
0.5p ordinary Purchase 380 20.7800 GBP
0.5p ordinary Purchase 482 20.8000 GBP
0.5p ordinary Purchase 513 20.7300 GBP
0.5p ordinary Purchase 533 20.7700 GBP
0.5p ordinary Purchase 547 20.7600 GBP
0.5p ordinary Purchase 579 20.7500 GBP
0.5p ordinary Purchase 627 20.7749 GBP
0.5p ordinary Purchase 740 20.7027 GBP
0.5p ordinary Purchase 908 20.7400 GBP
0.5p ordinary Purchase 918 20.8100 GBP
0.5p ordinary Purchase 1,032 20.7962 GBP
0.5p ordinary Purchase 1,080 20.7535 GBP
0.5p ordinary Purchase 1,745 20.7447 GBP
0.5p ordinary Purchase 1,808 20.7790 GBP
0.5p ordinary Purchase 2,349 20.7577 GBP
0.5p ordinary Purchase 10,345 20.7667 GBP
0.5p ordinary Purchase 11,047 20.7414 GBP
0.5p ordinary Purchase 21,622 20.7542 GBP
0.5p ordinary Sale 17 20.8250 GBP
0.5p ordinary Sale 37 20.8486 GBP
0.5p ordinary Sale 124 20.7750 GBP
0.5p ordinary Sale 155 20.7700 GBP
0.5p ordinary Sale 290 20.7650 GBP
0.5p ordinary Sale 301 20.8203 GBP
0.5p ordinary Sale 343 20.8050 GBP
0.5p ordinary Sale 347 20.7600 GBP
0.5p ordinary Sale 380 20.7800 GBP
0.5p ordinary Sale 422 20.7593 GBP
0.5p ordinary Sale 486 20.8000 GBP
0.5p ordinary Sale 579 20.7500 GBP
0.5p ordinary Sale 628 20.7702 GBP
0.5p ordinary Sale 660 20.7300 GBP
0.5p ordinary Sale 891 20.8033 GBP
0.5p ordinary Sale 908 20.7400 GBP
0.5p ordinary Sale 1,207 20.7969 GBP
0.5p ordinary Sale 1,566 20.7309 GBP
0.5p ordinary Sale 1,658 20.8100 GBP
0.5p ordinary Sale 2,524 20.7591 GBP
0.5p ordinary Sale 14,906 20.7588 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
0.5p ordinary CFD Long 37 20.8486 GBP
0.5p ordinary SWAP Long 205 20.7398 GBP
0.5p ordinary SWAP Long 422 20.7593 GBP
0.5p ordinary SWAP Long 1,002 20.8085 GBP
0.5p ordinary SWAP Long 1,648 20.7827 GBP
0.5p ordinary SWAP Short 224 20.7459 GBP
0.5p ordinary SWAP Short 549 20.7422 GBP
0.5p ordinary SWAP Short 685 20.8112 GBP
0.5p ordinary CFD Short 13,247 20.7385 GBP
0.5p ordinary SWAP Short 19,595 20.7685 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 7 Jun 2017
Contact name: Jay Supaya
Telephone number: 0207 773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170607005671/en/

Copyright Business Wire 2017

Date   Source Headline
20th Jul 20153:29 pmRNSDirector/PDMR Shareholding
15th Jul 20154:49 pmRNSHolding(s) in Company
26th Jun 20153:38 pmRNSDirector/PDMR Shareholding
26th Jun 20153:34 pmRNSDirector/PDMR Shareholding
25th Jun 20154:51 pmRNSAnnual Financial Report
22nd Jun 20155:01 pmRNSHolding(s) in Company
17th Jun 201512:04 pmRNSDirector/PDMR Shareholding
15th Jun 20155:53 pmRNSHolding(s) in Company
11th Jun 20157:00 amRNSFinal Results
10th Jun 20157:00 amRNSDirectorate Change
9th Jun 20152:00 pmRNSDirectorate Change
19th May 20152:13 pmRNSDirector/PDMR Shareholding
17th Apr 20151:39 pmRNSDirector/PDMR Shareholding
8th Apr 20157:00 amRNSTrading Statement
19th Mar 20157:00 amRNSAnalyst Presentation
18th Mar 20156:17 pmRNSDirector/PDMR Shareholding
18th Mar 20154:25 pmRNSDirector/PDMR Shareholding
18th Feb 20154:33 pmRNSDirector/PDMR Shareholding
18th Feb 20154:19 pmRNSDirector/PDMR Shareholding
11th Feb 20157:00 amRNSThird Quarter Trading Update
4th Feb 20155:27 pmRNSHolding(s) in Company
20th Jan 20154:48 pmRNSDirector/PDMR Shareholding
20th Jan 201512:20 pmRNSDirector Declaration
19th Jan 201510:06 amRNSDirector/PDMR Shareholding
15th Jan 20154:41 pmRNSDirector/PDMR Shareholding
12th Jan 20154:45 pmRNSDirector/PDMR Shareholding
6th Jan 20154:25 pmRNSDirector/PDMR Shareholding
17th Dec 20149:56 amRNSDirector/PDMR Shareholding
12th Dec 20143:50 pmRNSDirector/PDMR Shareholding
12th Dec 20141:49 pmRNSDirector/PDMR Shareholding
1st Dec 20144:26 pmRNSHolding(s) in Company
24th Nov 20144:16 pmRNSDirector/PDMR Shareholding
19th Nov 20144:31 pmRNSDirector/PDMR Shareholding
19th Nov 20144:14 pmRNSDirector/PDMR Shareholding
18th Nov 20144:07 pmRNSDirector/PDMR Shareholding
17th Nov 20145:18 pmRNSDirector/PDMR Shareholding
17th Nov 20145:03 pmRNSHolding(s) in Company
13th Nov 20147:00 amRNSHalf Yearly Report
7th Nov 20142:20 pmRNSHolding(s) in Company
6th Nov 20142:27 pmRNSHolding(s) in Company
16th Oct 20143:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSAnalyst Presentation
1st Oct 20147:00 amRNSAcquisition
29th Sep 20144:12 pmRNSDirector/PDMR Shareholding
26th Sep 20145:01 pmRNSHolding(s) in Company
26th Sep 20142:15 pmRNSHolding(s) in Company
25th Sep 20147:00 amRNSTrading Statement
17th Sep 20144:30 pmRNSDirector/PDMR Shareholding
12th Sep 201411:01 amRNSHolding(s) in Company
8th Sep 20147:00 amRNSAtkins acquires US based nuclear business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.